ArticleFrontiers in immunology2025

Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies.

Alessandra Aiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.